Insights from 2023 WCLC

 

Insights from 2023 WCLC
D

WCLC 2023 Insights: "Phase 3 AEGEAN Study - Neoadjuvant Durvalumab + Chemo Followed by Adjuvant Durvalumab in Resectable EGFRm NSCLC"

By Insights from 2023 WCLC FEATURING David Harpole
By Insights from 2023 WCLC FEATURING David Harpole
108 views
October 9, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
Videos
14:02

WCLC 2023 Insights: "MSI and MMR-D Define a Distinct Subset of Lung …

Insights from 2023 WCLC

S. Yang

119 views
05:32

Molecular and Clinical Characterization of NSCLC With MET Fusions

Insights from 2023 WCLC

C. Kim

164 views
08:59

WCLC 2023 Insights: "SWOG S1609 (DART) Phase 2 Basket Trial of Dual …

Insights from 2023 WCLC

Y. Chae

67 views
15:49

WCLC 2023 Insights: "NSCLC Microenvironment Subtypes Correlate with …

Insights from 2023 WCLC

D. Bansal

102 views
08:40

WCLC 2023 Insights: "PD-L1 Subgroups in the Phase 3 LUNAR Study - TT…

Insights from 2023 WCLC

R. Kotecha

69 views
05:48

WCLC 2023 Insights: "Association of TTF-1 Expression With Outcomes t…

Insights from 2023 WCLC

A. Di Federico

87 views
08:54

WCLC 2023 Insights: "AI as a First Read Filter in Lung Cancer Screen…

Insights from 2023 WCLC

H. Lancaster

417 views
07:13

WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSCLC Wi…

Insights from 2023 WCLC

S. Gadgeel

305 views
09:08

WCLC 2023 Insights: "Mechanisms of Resistance to KRAS G12C Inhibitor…

Insights from 2023 WCLC

B. Ricciuti

98 views
06:29

WCLC 2023 Insights: "KRYSTAL-1 - Two-Year Follow-Up of Adagrasib Mon…

Insights from 2023 WCLC

S. Gadgeel

174 views
09:57

WCLC 2023 Insights: "3-Year Outcomes & Correlative Analyses in Patie…

Insights from 2023 WCLC

B. Ricciuti

99 views
07:51

WCLC 2023 Insights: "Phase 3 AEGEAN Study - Neoadjuvant Durvalumab +…

Insights from 2023 WCLC

D. Harpole

108 views
06:28

WCLC 2023 Insights: "Results of the SQUINT Trial - Do MAPK1/MAPK3 Mu…

Insights from 2023 WCLC

G. Minuti

69 views
11:40

WCLC 2023 Insights: "Prognosis in Lung Adenocarcinoma With Upregulat…

Insights from 2023 WCLC

L. Zhang

81 views
09:12

WCLC 2023 Insights: "ILLUMINATE - Efficacy & Safety of Durvalumab-Tr…

Insights from 2023 WCLC

C. Khoon Lee

89 views
16:43

WCLC 2023 Insights: "Osimertinib in Resected EGFRm NSCLC - ADAURA Tr…

Insights from 2023 WCLC

A. Marinello

79 views
08:45

WCLC 2023 Insights: "Long-Term Outcomes by Radiation Technique for L…

Insights from 2023 WCLC

S. Chun

100 views